Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-04-26
2011-04-26
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S387300, C530S388100, C530S389100, C530S389200, C424S130100, C424S133100, C424S137100, C424S141100, C424S145100
Reexamination Certificate
active
07932363
ABSTRACT:
The present invention provides a human eosinophil-derived basic protein (EBPH) and polynucleotides which identify and encode EBPH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding EBPH and a method for producing EBPH. The invention also provides for use of EBPH and agonists, antibodies or antagonists specifically binding EBPH, in the prevention and treatment of diseases associated with expression of EBPH. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding EBPH for the treatment of diseases associated with the expression of EBPH. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding EBPH.
REFERENCES:
patent: 97/37022 (1997-10-01), None
Attwood Science 290: 471-473, 2000.
Skolnick et al. Trends in Biotech. 18: 34-39, 2000.
Li et al. PNAS 77: 3211-3214, 1980.
Lederman et al. Molecular Immunology 28: 1171-1181, 1991.
Houghten et al. (New Approaches to Immunization, Vaccines 86, Cold Spring Harbor Laboratory, p. 21-25, 1986).
Aoki et al. FEBS Lett. 279, 330-334, 1991.
Campbell Monoclonal Antibody Technology, 1984, Chapter 1, pp. 1-32.
Owens et al. JIM, 1994, 168:149-165.
Gleich et al.,J. Allergy Clin. Immun., 81(5)(1):776-781 (1990).
Frigas et al.,Mayo Clin. Proc., 56:345-353 (1991).
Filley et al.,Lancet, 2:11-16 (Jul. 3, 1982).
Sarmiento et al.,J. Immunol., 155:2211-2221 (1996).
Moy et al.,J. Immunol., 145:2626-2632 (1995).
Rohrbach et al.,J. Exp. Med., 145:1271-1274 (1990).
Kita et al.,The Journal of Immunology, 154:4749-4758 (1995).
Popken-Harris et al.,J. Immunol, 155:1472-1480 (1995).
Oxvig et al.,FEBS Lett., 341:213-217 (1994).
Abu-Ghazaleh,J. Membrane Biol., 128:153-164 (1992).
Wagner,Placenta, 15:625-640 (1994).
Maddox,J. Exp. Med., 160:29-41 (1984).
Oxvig,The Journal of Biological Chemistry, 270(23):13645-13651 (1995).
Brambati et al.,British Journal of Obstetrics and Gynecology, 100:324-326 (Apr. 1993).
Tewksbury et al.,J. Exp. Med., 168:1493-1498 (1988).
Barker et al.,J. Exp. Med., 168:1493-1498 (Sept. 1988).
Aoki et al.,FEBS Letters, 282(1):56-60 (1990), G1220291 & Gi 544241).
Barker et al.,Gene, 86:285-289 (1990).
Mikayama et al.,Proc. Natl. Acad. Sci. USA, 90:10056-10060 (1993).
Voet D. And Voet J.G., in:Biochemistry, Voet and Voet eds., John Wiley & Sons, Inc., New York, pp. 126-128 and 2228-2234 (1990).
GeneSeq entry W31527; May 21, 1998; Gentz R.L. et al. (1998).
Alignment Report; Apr. 10, 2000 (2000).
Whisstock et al.,Quarterly Rev. Immunol., (2003), 36(3):307-340.
Sequence Alignment of Accession AA779195 to Seq. ID No. 2.
Foley & Lardner LLP
Incyte Corporation
Wen Sharon
LandOfFree
Antibody that binds human eosinophil-derived basic protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody that binds human eosinophil-derived basic protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody that binds human eosinophil-derived basic protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666066